>
Organization
Medimetriks Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Medimetriks Pharmaceuticals, Inc.

... Pharmaceuticals (USA)Johnson & Johnson (USA)Kao Corporation (Japan)Laboratorios Leti SL. (Spain)L'Oral S.A. (France)Medimetriks Pharmaceuticals, Inc. (USA)Merz Pharma GmbH & Co. KGaA (Germany)NEOCUTIS (USA)Otsuka Pharmaceutical Co., Ltd. ...
... Ardelyx to commercialize tenapanor Strategic Lending and Investments Received US$22,757 from Medimetriks Pharmaceuticals Inc. ("Medimetriks") for partial loan repayment, interest and feesReceived US$4,460 as a ...
... early repayment of $ 2,488 Received additional 1,577,363 common shares of Medimetriks Pharmaceuticals Inc. ('Medimetriks') initially valued at US$ 2,453 Received dividends of $ 4,984 ...
... early repayment of $2,488 -- Received additional 1,577,363 common shares of Medimetriks Pharmaceuticals Inc. ("Medimetriks") initially valued at US$2,453 -- Received dividends of $4,984 from ...
... -- Received dividends of $4,984 from Medison Biotech (1995) Ltd. Pharmaceuticals Inc. ("Medimetriks") initially valued at US$2,453 -- Received additional 1,577,363 common shares of Medimetriks ...
... GUD) ('Knight'), a leading Canadian specialty pharmaceutical company, announced today that Medimetriks Pharmaceuticals Inc. ('Medimetriks') has prepaid US$ 20 million of Knight's US$ 23 million ...
... (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Medimetriks Pharmaceuticals Inc. ("Medimetriks") has prepaid US$20 million of Knight's US$23 million secured strategic ...
... Medimetriks Pharmaceuticals, Inc. today announced that the Company divested exclusive U.S. rights for Xepi(TM) ...
... Medimetriks Pharmaceuticals, Inc.announced today that the U.S. Food and Drug Administration (FDA) approved Xepi(TM) ...
... Medimetriks Pharmaceuticals, Inc. today announced positive results of its Phase 2, multi-center, open-label, maximal ...
Subscribe now for full coverage on Medimetriks Pharmaceuticals, Inc.
Start My Free Trial